Clear Words Are Not Enough: What Patient-Friendly Communication Really Means
Clear words are only the beginning. Truly patient-friendly cancer communication considers timing, emotion, individual needs and understanding, help...
A Break at Sea for Patients with Digestive Cancers
Nine patients with digestive cancers and four physicians swapped hospital corridors for open water, sharing a day of sailing, connection and renewe...
Launching IMPACT: Advancing New Hope for Peritoneal and Pleural Metastases
The Horizon Europe funded IMPACT project has officially launched, bringing together 13 European partners to evaluate innovative aerosolised chemoth...
Learning Together to Improve Lives: Highlights from the 11th DiCE Masterclass 2026
The 11th DiCE Masterclass brought together patient advocates, healthcare professionals, and researchers to explore the latest advances in digestive...
Strengthening Patient Voices at WECAN Academy 2026
DiCE advocates joined more than 100 patient leaders from 34 countries at WECAN Academy 2026, gaining new advocacy skills, sharing European initiati...
Unlocking New Hope for Small Bowel Adenocarcinoma
A rare cancer that deserves more answers: progress from a Small Bowel Adenocarcinoma project                           Â...
KI-COMPASS: Using AI to Transform Follow-Up Care After Gastroesophageal Cancer
KI-COMPASS is exploring how artificial intelligence, wearable technology and clinical data can personalise follow-up care after gastroesophageal ca...
New Patient-Led Survey Explores What Meaningful Cancer Support Really Looks Like
Every word matters. Take part in this patient-led survey exploring what meaningful cancer support truly looks like. Share your experience and help ...
Is There Such a Thing as a Perfect Day?
Sixty-five participants and more than 600 donors united in Valkenburg through Harry’s Tegenkracht, raising €25,126 for oesophageal cancer r...
DiCE Helps Shape Global Conversations on Access to Medicines at Making Access Happen 2026
DiCE helped drive global conversations on access to medicines, biosimilars, patient advocacy, and digital innovation at Making Access Happen 2026, ...